Innoviva (INVA) Operating Expenses (2016 - 2025)
Innoviva's Operating Expenses history spans 16 years, with the latest figure at $41.0 million for Q3 2025.
- For Q3 2025, Operating Expenses rose 37.59% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $107.2 million, up 13.66%, while the annual FY2025 figure was $143.9 million, 11.27% up from the prior year.
- Operating Expenses reached $41.0 million in Q3 2025 per INVA's latest filing, up from $34.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $87.7 million in Q2 2022 to a low of -$219.2 million in Q3 2022.
- Average Operating Expenses over 5 years is $12.8 million, with a median of $31.9 million recorded in 2025.
- The largest YoY upside for Operating Expenses was 1956.38% in 2022 against a maximum downside of 765.76% in 2022.
- A 5-year view of Operating Expenses shows it stood at -$25.3 million in 2021, then plummeted by 765.76% to -$219.2 million in 2022, then surged by 91.47% to -$18.7 million in 2023, then soared by 259.26% to $29.8 million in 2024, then soared by 37.59% to $41.0 million in 2025.
- Per Business Quant, the three most recent readings for INVA's Operating Expenses are $41.0 million (Q3 2025), $34.4 million (Q2 2025), and $31.9 million (Q1 2025).